Cytokinetics Reports Data For Ispinesib In Recurrent And/or Metastatic Head And Neck Squamous Cell Carcinoma Medical News Today
Cytokinetics, Incorporated (Nasdaq: CYTK) announced results from a planned interim analysis following Stage 1 of a two-stage Phase II clinical trial of ispinesib administered as monotherapy in the treatment of patients with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC). [click link for full article]
Cytokinetics Reports Data for Ispinesib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma FinanzNachrichten
SOUTH SAN FRANCISCO, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Cytokinetics, ( Nachrichten ) Incorporated announced results from a planned interim analysis following Stage 1 of a two-stage Phase II clinical trial of ispinesib administered as monotherapy in the treatment of patients with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC). This clinical trial was conducted by
FDA Approves ZOLINZATM Vorinostat for the Treatment of Cutaneous Manifestations in Patients with Cutaneous T-Cell Business Wire via Yahoo! Finance
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has approved oral ZOLINZA 400 mg once daily for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma , a form of non-Hodgkin's lymphoma, who have progressive, persistent or recurrent disease on or following two systemic therapies.
Program’s focus: Skin cancer Times Leader
Skin cancer is now the world’s most common cancer and is occurring at epidemic rates. More than a million new cases of skin cancer are diagnosed in the United States every year.
FDA Approves ZOLINZA for the Treatment of Cutaneous Manifestations in Patients with Cutaneous T-cell Lymphoma Who Have PR Web via Yahoo! News
Whitehouse Station, N.J. (PRWEB) October 8, 2006 -- Merck & Co.
FDA Approves ZOLINZA for the Treatment of Cutaneous Manifestations in Patients with Cutaneous T-cell Lymphoma Who Have PR Web
ZOLINZA is Merck's first anticancer treatment in decades to be approved by the FDA (PRWeb Oct 8, 2006) Trackback URL: http://www.prweb.com/chachingpr.php/U3F1YS1aZXRhLUhhbGYtRmFsdS1JbnNlLVplcm8=
DCGI approves Merck's Erbitux for Treatment of Head & Neck Cancer in India PharmaBiz
Merck Specialities has received marketing approval for Erbitux, its gold standard new-targeted cancer therapy drug, for the treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) cancer.
What is Esophageal Cancer? BellaOnline
Did you ever wonder what esophageal cancer is? This article is about how one can get cancer, from acid reflux (GERD) after a long period of time!
Lots of fruit may reduce oral cancer risk in men Reuters via Yahoo! News
Men who consume high quantities of fruits, especially citrus fruits and juices, have a significantly lower risk of developing oral premalignant lesions, irregular tissue that has not yet developed into cancer, according to the findings published in the American Journal of Epidemiology.
Skin Cancer Screening Tour Continues Its Life-Saving Trip PR Newswire via Yahoo! Finance
Bradley Pharmaceuticals, Inc. announced today that to date, The Skin Cancer Screening Tour, sponsored jointly by the Doak Dermatologics subsidiary of Bradley Pharmaceuticals and The Skin Cancer Foundation, has provided free screenings for more than 5000 individuals, and raised considerable public awareness of the importance of regular visits to a dermatologist for early detection of skin cancer.

AAD - Squamous Cell Carcinoma
Squamous cell carcinoma (SCC) is the second most common cancer of the skin. Squamous cell carcinoma is a tumor that arises in the outer layer of the skin
Squamous cell carcinoma. DermNet NZ
Authoritative facts about the skin from the New Zealand Dermatological Society.
Squamous cell carcinoma - Wikipedia, the free encyclopedia
Biopsy of a highly differentiated squamous cell carcinoma of the mouth. Squamous cell carcinoma is usually developed in the epithelial layer of the skin
squamous cell carcinoma
A biopsy of the base of one of these horny tumors revealed squamous cell carcinoma. He declined treatment saying that it had been there for a long time and
Squamous Cell Carcinoma - oncologychannel
Sqamous cell carcinoma involves the malignant transformation and proliferation of squamous cells. The squamous cell is the most abundant cell in the


Squamous cell carcinoma - Wikipedia, the free encyclopedia
Biopsy of a highly differentiated squamous cell carcinoma of the mouth. Squamous cell carcinoma is usually developed in the epithelial layer of the skin
squamous cell carcinoma
A biopsy of the base of one of these horny tumors revealed squamous cell carcinoma. He declined treatment saying that it had been there for a long time and
Squamous Cell Carcinoma - oncologychannel
Sqamous cell carcinoma involves the malignant transformation and proliferation of squamous cells. The squamous cell is the most abundant cell in the
Squamous Cell Carcinoma
Detailed article from veterinary perspective of the condition, including Skin, Tonsillar, Tongue and Nasal Planum variants.
eMedicine - Pathology: Squamous Cell Carcinoma : Article by Gerard
Pathology: Squamous Cell Carcinoma - Nomenclature Squamous cell carcinoma (SCC) is an epithelial malignancy with morphologic features of squamous cell
Female Genital Pathology
Here is another cervical squamous cell carcinoma. Note the IUD string protruding from the cervix. This implies that someone could have done a Pap smear when
Guidelines of Care for Cutaneous Squamous Cell Carcinoma
Task Force on Cutaneous Squamous Cell Carcinoma: Stuart Salasche, MD, Specific risk factors of the given cutaneous squamous cell carcinoma that may make
DermAtlas: Online Dermatology Image Library dermatology image
It is a good example of an acantholytic squamous cell carcinoma, A biopsy revealed a squamous cell carcinoma which was excised and repaired with a flap.